medicine-products/spinal-instruments-4614-1/;msg18067;topicseen
| We're sorry, that page (http://www.bio-medicine.org/medicine-products/spinal-instruments-4614-1/;msg18067;topicseen) was not found. Search medicine products spinal instruments 4614 1 ;msg18067;topicseen at Google Search medicine products spinal instruments 4614 1 ;msg18067;topicseen at Yahoo Search medicine products spinal instruments 4614 1 ;msg18067;topicseen at Msn |
Breaking Biology Technology:Dendreon Announces Pricing of Common Stock Offering 2Dendreon Announces Pricing of Common Stock Offering 3NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont 2NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont 3YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 2YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 3YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 4Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 2Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products 3
[0] Dendreon Announces Pricing of Common Stock Offering[0] NEI Awards a Two-Year $2.18 Million SBIR Grant to Aciont [0] YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT[0] Vivakor Receives $5 Million Licensing and Purchase Agreement for Nutraceutical Products
Breaking Medicine Technology:RetireSafe Announces Intention to Key Vote Senator Dorgan's Drug Importation Amendment (SA 2793) 2Dynatronics Receives 180-Day NASDAQ Extension 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 2Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug 3Give Shoes the 26apos 3B1 2 3 Test 26apos 3B During Back To School Shopping 54914 1Give Shoes the 26apos 3B1 2 3 Test 26apos 3B During Back To School Shopping 54914 2Give Shoes the 26apos 3B1 2 3 Test 26apos 3B During Back To School Shopping 54914 3Watching stem cells repair the human brain 54909 1Watching stem cells repair the human brain 54909 2Breakthrough uses light to manipulate cell movement 54904 1
[0] RetireSafe Announces Intention to Key Vote Senator Dorgan's Drug Importation Amendment (SA 2793)[0] Dynatronics Receives 180-Day NASDAQ Extension[0] Berger & Montague, P.C., Files Class Action Against Hemispherx Biopharma, Inc. Extending the End of the Class Period to December 1, 2009, When the Company Announced That the FDA Found No Evidence of Efficacy of Its Drug
| Copyright © 2003-2007 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |